Navigation Links
The Chris Elliott Fund Commends New Bill to Improve Access to Oral Chemotherapy Drugs
Date:5/13/2013

Seattle, WA (PRWEB) May 13, 2013

The Chris Elliott Fund commends the work of Congressman Brian Higgins, NY-26 , for introducing the Cancer Drug Coverage Parity Act which would require health insurance companies to equally cover and reimburse intravenous/injectable and orally administered anti-cancer medication. “Doctors, not insurance companies, should decide the best course of treatment for cancer patients. This legislation will better enable patients access to the best available treatments that will extend and improve their quality of life” said Higgins in a press release on the introduction of the act on May 2nd 2013.

Many brain tumor patients face mounting costs throughout treatment, one of which can be oral chemo therapy treatment. “There are so many great treatments out there and unfortunately too often brain cancer patients are left with the question of who is going to pay for it” says Dellann Elliott Mydland, Chris Elliott Fund Founder & President, “it is unfortunate to see individuals and families bankrupted by cancer care and treatment, and this Act aims to change that.” The Chris Elliott Fund supports this bill and offers that it is a great bridge between science and healthcare, finding affordable solutions for the care people need. It is part of CEF's mission to provide immediate equal access to advance treatment, in hopes to end brain cancer. Financial concerns are a specific focus of The Chris Elliott Fund, earlier this year the organization hosted a 2-part webinar in their Brains Matter Webinar Series on “A Brain Tumor Patient’s Guide to Insurance & Financial Resources”. For updates on webinars and educational information, or to follow news on this Act email the Chris Elliott Fund at WeCare(at)EndBrainCancer(dot)com.

About the Chris Elliott Fund:
The Chris Elliott Fund (CEF) is a patient advocacy organization and national 501(c)(3) non-profit with corporate offices in Seattle, Washington, with goals to end brain cancer through education, advocacy, awareness and support. Established in 2002, CEF has grown to provide support nationally for brain cancer and brain tumor patients seeking guidance, advice, and assistance to demystify finding the absolute best course of treatment for their brain cancer or brain tumor. The organization and its advocates, on average, serve 500-800 patients and caregivers per month, free of charge. If we can help, please contact us at WeCare(at)EndBrainCancer(dot)com.

Read the full story at http://www.prweb.com/releases/ChrisElliottFundSupports/CancerCoverageParityAct/prweb10707754.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Christopher Oliver Agency Creates Advanced Tracking System for Controversial Law of Attraction Weight Loss Book
2. The Chris Elliott Fund to Honor the Late Kathi Goertzen, Longtime Western Washington News Anchor, with Inspiration Award at May 16th Brains Matter Auction and Luncheon
3. Turmeric Products Are Not All Alike, Christian Wilde's Newly Released, Enhanced Turmeric+ Formula (with 7 Additional Synergizing Ingredients) Is a Totally Unique.
4. Christian Alcohol Rehab Announced by Recovery Associates
5. Actors, Models and Talent for Christ Announces New Audition Sites for Up and Coming Talent of All Ages
6. Actors, Models and Talent for Christ Grad Julian Silva Cast in Les Miserables US and Canada Tour 2013 performing in New York April 30-May 5
7. Actors, Models and Talent for Christ (AMTC) Prepares for Auditions in Dallas on Monday, May 6th
8. Nashville Awaits Talent Auditions This Friday, April 26th Hosted by Actors, Models and Talent for Christ
9. Actors, Models & Talent for Christ Graduate, Taylor Beckham, Is Stolen by Team Blake And Stays in The Voice Competition
10. Actors, Models & Talent for Christ Graduate, Charles Michael Davis in Grey’s Anatomy and Big Screen Movie Another Stateside
11. Actors, Models and Talent for Christ (AMTC) Prepares for Atlanta Auditions on Monday, April 29th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... ... of the American Academy of Orthopaedic Surgeons , points out that therapeutic ... suffering from pain or injury. According to the report, a wider scope of ...
(Date:8/22/2017)... ... 22, 2017 , ... The old adage “you are what ... eating healthy foods. But this well-known piece of nutrition advice ignores that an ... carbohydrates—depends not only on properties of the food but also on properties of ...
(Date:8/22/2017)... del Rey, CA (PRWEB) , ... August 22, ... ... of revenue cycle management (RCM) solutions, announced recently the availability of a new ... HIM community in appreciation for their service to the healthcare industry. E/M coding ...
(Date:8/22/2017)... ... ... “Wilderness Voices”: a collection of poetry inspired by life on a Kentucky ... published author, Martha McKown, an ordained United Methodist minister with graduate degrees in Religious ... her older sisters studied High School literature. She loved the early English folk ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... is the Founder and Managing Member for t4 Leadership Development & Consulting. He ... to his definition of “success”: physician leadership development, servant leadership, data driven process ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Inc. announced today that its fully owned USA ... York City Office in Yonkers, New York ... (TWO 2 ) homecare therapy. This new East Coast location has ... under the company,s DMEPOS accreditation for Home/Durable Medical Equipment Services. ... Advanced Oxygen Therapy Inc. New ...
(Date:8/11/2017)... 11, 2017 DarioHealth Corp. (NASDAQ: DRIO), a ... big data solutions, today announced that it will release ... and host a conference call at 9:00am ET. The ... financial results and its strategy and outlook for the ... Erez Raphael , Chief Executive Officer, and ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
Breaking Medicine Technology: